logo
Plus   Neg
Share
Email

Crosshair Energy Appoints Mark Ludwig As President & CEO

Crosshair Energy Corp. (CXZ,CXX.TO) announced the appointment of Mark Ludwig, as President & Chief Executive Officer effective April 30, 2012 and the appointment of Chris Healey to Crosshair's Board of Directors, effective April 25, 2012.

Ludwig was appointed Chief Operating Officer in July 2011 and brings more than 30 years of mining, management and mineral exploration and development experience to his new role. Ludwig takes over from Stewart Wallis, who is retiring from his role as President & CEO but will remain as a member of Crosshair's Board of Directors and a consultant to Crosshair as well as the entire Forbes West group of companies.

Prior to joining Crosshair, Ludwig was the Vice President of Operations of Neutron Energy. From 2005 to 2008 he was employed by Hecla Mining Company as a Senior Mining Engineer/Project Manager and later as Manager of Corporate Development. From 1984 until 2005 he worked in various positions with BHP Billiton including as a Senior Project and Mining Engineer. Mr. Ludwig will continue to be based in Denver, Colorado.

Healey will be taking over the Board seat vacated by Ian Smith, who is retiring as a director of Crosshair.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Billionaire entrepreneur Elon Musk on Thursday showed off his concept for the Loop, a high-speed underground public transportation system that will carry up to 16 people and travel at 150 miles per hour. At the Boring Company Information Session, Musk and project leader Steve Davis provided details of the underground mass transit tunnels that the Boring Co. plans to build beneath Los Angeles. Raden has become the second smart luggage company to shut down this month after major U.S. airlines banned smart luggage with non-removable batteries earlier this year. In a statement on its website, Raden said that it is no longer in operation and that all existing shipments have been processed for delivery. The company is shuttering after three years of operation. Shares of AstraZeneca were losing around 2 percent in the London trading after the British drug major reported Friday lower profit in its first quarter amid weak margin, despite growth in product sales. Further, the company reiterated its outlook for fiscal 2018. The level of Externalisation Revenue, divestment timing and investment in launches impacted the overall results.
Follow RTT